Gernot Walko

Queen Mary University of London — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

25h-index2.0kcitations54works0.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Skin and Cellular Biology Research(26), Cellular Mechanics and Interactions(17), Hippo pathway signaling and YAP/TAZ(13), Polysaccharides and Plant Cell Walls(11), Cell Adhesion Molecules Research(8)

Publications54 total

P44 Investigating the effects of YAP–TEAD inhibition on cancer-associated fibroblasts in cutaneous squamous cell carcinoma
British Journal of Dermatology·2026
411 Investigating the roles of YAP and TAZ in human cutaneous squamous cell carcinoma progression
Journal of Investigative Dermatology·2025Open Access
YAP engages RIF1 to dampen replication stress-induced DNA damage in human squamous cell carcinoma
2024· 1 citedOpen Access
409 A non-transcriptional function of the oncoprotein YAP contributes to squamous cell carcinogenesis
Journal of Investigative Dermatology·2024
Boosting Skin Wound Healing by Agrin-Mediated YAP/TAZ Activation
Journal of Investigative Dermatology·2024· 2 citedOpen Access
P04 How fibroblasts and azathioprine prepare the soil for cutaneous squamous cell carcinoma
British Journal of Dermatology·2024
O16 Understanding the pleiotropic effects of the Rho-kinase inhibitor Y-27632 on human keratinocytes
British Journal of Dermatology·2024
Generation of 3D Fibroblast-Derived Extracellular Matrix and Analysis of Tumor Cell-Matrix Interactions and Signaling
Methods in molecular biology·2024Open Access
Data Supplement from Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP46
2023Open Access
Data from Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP46
2023Open Access
Data Supplement from Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP46
2023Open Access
Data Supplement from Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP46
2023Open Access
Data Supplement from Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP46
2023Open Access
Data Supplement from Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP46
2023Open Access
Data Supplement from Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP46
2023Open Access
Data from Calpain-Mediated Integrin Deregulation as a Novel Mode of Action for the Anticancer Gallium Compound KP46
2023Open Access
ESDR430 - A non-transcriptional role of the oncoprotein YAP in cutaneous squamous cell carcinoma.
2022
Targeting the Hippo/<scp>YAP</scp>/<scp>TAZ</scp> signalling pathway: Novel opportunities for therapeutic interventions into skin cancers
Experimental Dermatology·2022· 25 citedOpen Access
Plectin dysfunction in neurons leads to tau accumulation on microtubules affecting neuritogenesis, organelle trafficking, pain sensitivity and memory
Neuropathology and Applied Neurobiology·2020· 28 citedOpen Access
581 A genome-wide screen identifies YAP/WBP2/TEAD interplay conferring growth advantage on human epidermal stem cells
Journal of Investigative Dermatology·2019· 2 cited
page 1 of 3Next →

Frequent Co-authors

Gerhard Wiche(22), Ute Jungwirth(12), Fiona M. Watt(9), Irmgard Fischer(8), Siegfried Reipert(8), Priyalakshmi Viswanathan(7), Lilli Winter(6), Angela Oliveira Pisco(6), Kifayathullah Liakath‐Ali(6), Ajay Mishra(6), Walter Berger(6), Martin Gregor(5), Selma Osmanagic‐Myers(5), Emanuel Rognoni(5), Bénédicte Oulès(5), Günther A. Rezniczek(5), Johannes Gojo(5), Theresa Tuder(5), Martin Holcmann(5), Thomas Schöfl(5)